These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
807 related items for PubMed ID: 18465373
1. Anterior cingulate glutamate-glutamine levels predict symptom severity in women with obsessive-compulsive disorder. Yücel M, Wood SJ, Wellard RM, Harrison BJ, Fornito A, Pujol J, Velakoulis D, Pantelis C. Aust N Z J Psychiatry; 2008 Jun; 42(6):467-77. PubMed ID: 18465373 [Abstract] [Full Text] [Related]
2. Reduced anterior cingulate glutamatergic concentrations in childhood OCD and major depression versus healthy controls. Rosenberg DR, Mirza Y, Russell A, Tang J, Smith JM, Banerjee SP, Bhandari R, Rose M, Ivey J, Boyd C, Moore GJ. J Am Acad Child Adolesc Psychiatry; 2004 Sep; 43(9):1146-53. PubMed ID: 15322418 [Abstract] [Full Text] [Related]
3. Functional and biochemical alterations of the medial frontal cortex in obsessive-compulsive disorder. Yücel M, Harrison BJ, Wood SJ, Fornito A, Wellard RM, Pujol J, Clarke K, Phillips ML, Kyrios M, Velakoulis D, Pantelis C. Arch Gen Psychiatry; 2007 Aug; 64(8):946-55. PubMed ID: 17679639 [Abstract] [Full Text] [Related]
4. 1H-MRS of the anterior cingulate cortex in childhood and adolescent obsessive-compulsive disorder: a case-control study. Ortiz AE, Ortiz AG, Falcon C, Morer A, Plana MT, Bargalló N, Lázaro L. Eur Neuropsychopharmacol; 2015 Jan; 25(1):60-8. PubMed ID: 25499604 [Abstract] [Full Text] [Related]
5. Brain magnetic resonance spectroscopy in obsessive-compulsive disorder: the importance of considering subclinical symptoms of anxiety and depression. Bédard MJ, Chantal S. Psychiatry Res; 2011 Apr 30; 192(1):45-54. PubMed ID: 21377338 [Abstract] [Full Text] [Related]
7. Brain neurochemistry in unmedicated obsessive-compulsive disorder patients and effects of 12-week escitalopram treatment: 1 H-magnetic resonance spectroscopy study. Parmar A, Sharan P, Khandelwal SK, Agarwal K, Sharma U, Jagannathan NR. Psychiatry Clin Neurosci; 2019 Jul 30; 73(7):386-393. PubMed ID: 30973183 [Abstract] [Full Text] [Related]
8. A magnetic resonance spectroscopy investigation of obsessive-compulsive disorder and anxiety. Whiteside SP, Port JD, Deacon BJ, Abramowitz JS. Psychiatry Res; 2006 Mar 31; 146(2):137-47. PubMed ID: 16507346 [Abstract] [Full Text] [Related]
9. Neurochemical changes in welders revealed by proton magnetic resonance spectroscopy. Chang Y, Woo ST, Lee JJ, Song HJ, Lee HJ, Yoo DS, Kim SH, Lee H, Kwon YJ, Ahn HJ, Ahn JH, Park SJ, Weon YC, Chung IS, Jeong KS, Kim Y. Neurotoxicology; 2009 Nov 31; 30(6):950-7. PubMed ID: 19631686 [Abstract] [Full Text] [Related]
11. White matter abnormalities in obsessive-compulsive disorder: a diffusion tensor imaging study. Szeszko PR, Ardekani BA, Ashtari M, Malhotra AK, Robinson DG, Bilder RM, Lim KO. Arch Gen Psychiatry; 2005 Jul 31; 62(7):782-90. PubMed ID: 15997020 [Abstract] [Full Text] [Related]
12. Proton magnetic resonance spectroscopy in obsessive-compulsive disorder: evidence for reduced neuronal integrity in the anterior cingulate. Tükel R, Aydın K, Ertekin E, Özyıldırım SŞ, Taravari V. Psychiatry Res; 2014 Dec 30; 224(3):275-80. PubMed ID: 25241042 [Abstract] [Full Text] [Related]
13. Decreased caudate N-acetyl-l-aspartic acid in pediatric obsessive-compulsive disorder and the effects of behavior therapy. Whiteside SP, Abramowitz JS, Port JD. Psychiatry Res; 2012 Apr 30; 202(1):53-9. PubMed ID: 22704757 [Abstract] [Full Text] [Related]
14. A 1H magnetic resonance spectroscopy study in adults with obsessive compulsive disorder: relationship between metabolite concentrations and symptom severity. Starck G, Ljungberg M, Nilsson M, Jönsson L, Lundberg S, Ivarsson T, Ribbelin S, Ekholm S, Carlsson A, Forssell-Aronsson E, Carlsson ML. J Neural Transm (Vienna); 2008 Jul 30; 115(7):1051-62. PubMed ID: 18528631 [Abstract] [Full Text] [Related]
15. Cerebral diffusion tensor imaging and in vivo proton magnetic resonance spectroscopy in patients with fulminant hepatic failure. Saksena S, Rai V, Saraswat VA, Rathore RS, Purwar A, Kumar M, Thomas MA, Gupta RK. J Gastroenterol Hepatol; 2008 Jul 30; 23(7 Pt 2):e111-9. PubMed ID: 17924951 [Abstract] [Full Text] [Related]
16. Spectroscopic abnormalities in the pregenual anterior cingulate cortex in obsessive-compulsive disorder using proton magnetic resonance spectroscopy: a controlled study. Kosová E, Pajuelo D, Fajnerová I, Greguš D, Brunovský M, Stopková P, Škoch A, Fürstová P, Španiel F, Horáček J. BMC Psychiatry; 2023 Oct 10; 23(1):734. PubMed ID: 37817131 [Abstract] [Full Text] [Related]
17. Cortical neurochemistry in euthymic patients with bipolar I disorder. Scherk H, Backens M, Schneider-Axmann T, Usher J, Kemmer C, Reith W, Falkai P, Gruber O. World J Biol Psychiatry; 2009 Oct 10; 10(4):285-94. PubMed ID: 19921970 [Abstract] [Full Text] [Related]
18. Localized functional neurochemical marker abnormalities in dorsolateral prefrontal cortex in pediatric obsessive-compulsive disorder. Russell A, Cortese B, Lorch E, Ivey J, Banerjee SP, Moore GJ, Rosenberg DR. J Child Adolesc Psychopharmacol; 2003 Oct 10; 13 Suppl 1():S31-8. PubMed ID: 12880498 [Abstract] [Full Text] [Related]
19. Effects of intensive cognitive-behavioral therapy on cingulate neurochemistry in obsessive-compulsive disorder. O'Neill J, Gorbis E, Feusner JD, Yip JC, Chang S, Maidment KM, Levitt JG, Salamon N, Ringman JM, Saxena S. J Psychiatr Res; 2013 Apr 10; 47(4):494-504. PubMed ID: 23290560 [Abstract] [Full Text] [Related]
20. Review of 1H magnetic resonance spectroscopy findings in major depressive disorder: a meta-analysis. Yildiz-Yesiloglu A, Ankerst DP. Psychiatry Res; 2006 Jun 30; 147(1):1-25. PubMed ID: 16806850 [Abstract] [Full Text] [Related] Page: [Next] [New Search]